Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Tech Transfer Awards
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • NIH IRP Access Planning Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NIEHS

DIAGNOSTIC METHODS AND GENE THERAPY USING REAGENTS DERIVED FROM THE HUMAN METASTASIS SUPPRESSOR GENE KAI1

  • Read more about DIAGNOSTIC METHODS AND GENE THERAPY USING REAGENTS DERIVED FROM THE HUMAN METASTASIS SUPPRESSOR GENE KAI1
Patent Cooperation Treaty
PCT/US1996/005848
Filed on 1996-04-25

ULTRASELECTIVE OPIOIDMIMETIC PEPTIDES AND PHARMACOLOGICAL AND THERAPEUTIC USES THEREOF

  • Read more about ULTRASELECTIVE OPIOIDMIMETIC PEPTIDES AND PHARMACOLOGICAL AND THERAPEUTIC USES THEREOF
Patent Cooperation Treaty
PCT/US1995/015510
Filed on 1995-11-30

METHOD FOR DIAGNOSING A PREDISPOSITION FOR BREAST AND OVARIAN CANCER

  • Read more about METHOD FOR DIAGNOSING A PREDISPOSITION FOR BREAST AND OVARIAN CANCER
Patent Cooperation Treaty
PCT/US1995/010220
Filed on 1995-08-11

17q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE

  • Read more about 17q-LINKED BREAST AND OVARIAN CANCER SUSCEPTIBILITY GENE
Patent Cooperation Treaty
PCT/US1995/010203
Filed on 1995-08-11

A CHIMERIC PROTEIN THAT HAS A HUMAN RHO MOTIF AND DEOXYRIBONUCLEASE ACTIVITY

  • Read more about A CHIMERIC PROTEIN THAT HAS A HUMAN RHO MOTIF AND DEOXYRIBONUCLEASE ACTIVITY
Patent Cooperation Treaty
PCT/US1993/006645
Filed on 1993-07-14

CHARACTERIZATION OF ESTROGEN RESPONSIVE MOUSE LACTOFERRIN PROMOTER

  • Read more about CHARACTERIZATION OF ESTROGEN RESPONSIVE MOUSE LACTOFERRIN PROMOTER
Patent Cooperation Treaty
PCT/US1992/009459
Filed on 1992-11-12

PREVENTION OF DRUG-INDUCED AGRANULOCYTOSIS WITH FREE RADICAL SCAVENGERS

  • Read more about PREVENTION OF DRUG-INDUCED AGRANULOCYTOSIS WITH FREE RADICAL SCAVENGERS
Patent Cooperation Treaty
PCT/US1992/009126
Filed on 1992-10-30

A METHOD FOR DETECTING A DIFFERENTIATION MARKER IN NORMAL AND CARCINOMA CELLS AND IN BIOLOGICAL SAMPLES AND BODY FLUID

  • Read more about A METHOD FOR DETECTING A DIFFERENTIATION MARKER IN NORMAL AND CARCINOMA CELLS AND IN BIOLOGICAL SAMPLES AND BODY FLUID
Patent Cooperation Treaty
PCT/US1992/009205
Filed on 1992-10-28

PHI X174 TRANSGENIC MAMMALS

  • Read more about PHI X174 TRANSGENIC MAMMALS
Patent Cooperation Treaty
PCT/US1992/004593
Filed on 1992-06-05

System For in vivo Site-Directed Mutagenesis Using Oligonucleotides

  • Read more about System For in vivo Site-Directed Mutagenesis Using Oligonucleotides
Patent Cooperation Treaty
PCT/US2002/023634
Filed on 2002-07-26

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 31
  • Page 32
  • Page 33
  • Page 34
  • Page 35
  • Page 36
  • Page 37
  • Page 38
  • Page 39
  • …
  • Next page ››
  • Last page Last »
Subscribe to NIEHS
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health